ESR2 and myeloid sarcoma: As ESR2 expression was strongly correlated with latency III traits, dependent on gender, and we had previously identified sexual dimorphism in associations of MS risk SNPs with gene expression, we next tested for correlations of expression of these MS risk genes with ESR2 and latency III traits.